Cryptotanshinone promotes brown fat activity by AMPK activation to inhibit obesity
Open Access
- 1 January 2024
- journal article
- research article
- Published by XMLink in Nutrition Research and Practice
- Vol. 18 (4) , 479-497
Abstract
Ni J, et al. Nutr Res Pract. 2024 Aug;18(4):479-497. https://doi.org/10.4162/nrp.2024.18.4.479Keywords
Funding Information
- Agriculture and Social Development in Hangzhou (20211231Y128)
This publication has 44 references indexed in Scilit:
- Upstream Determinants of Overweight and Obesity in EuropeCurrent Obesity Reports, 2023
- Development and structure–activity relationships of tanshinones as selective 11β-hydroxysteroid dehydrogenase 1 inhibitorsNatural Products and Bioprospecting, 2022
- Perfluorooctane sulfonate promotes hepatic lipid accumulation and steatosis in high‐fat diet mice through AMP‐activated protein kinase/acetyl‐CoA carboxylase (AMPK/ACC) pathwayJournal of Applied Toxicology, 2022
- Health consequences of obesity and projected future obesity health burden in ChinaObesity, 2022
- Salidroside Activates the AMP‐Activated Protein Kinase Pathway to Suppress Nonalcoholic Steatohepatitis in MiceHepatology, 2021
- AMPK: a key regulator of energy stress and calcium-induced autophagyJournal of Molecular Medicine, 2021
- The role of AMPK in metabolism and its influence on DNA damage repairMolecular Biology Reports, 2020
- Emerging Role of AMPK in Brown and Beige Adipose Tissue (BAT): Implications for Obesity, Insulin Resistance, and Type 2 DiabetesCurrent Diabetes Reports, 2018
- Cryptotanshinone promotes commitment to the brown adipocyte lineage and mitochondrial biogenesis in C3H10T1/2 mesenchymal stem cells via AMPK and p38-MAPK signalingBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2017
- New developments in the chemistry and biology of the bioactive constituents of tanshenMedicinal Research Reviews, 2006